David Colleran - 14 Mar 2026 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, General Counsel, Corp Sec
Signature
/s/ David Colleran
Issuer symbol
ANIK
Transactions as of
14 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 19:47:22 UTC
Previous filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Colleran David EVP, General Counsel, Corp Sec C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD /s/ David Colleran 17 Mar 2026 0001646558

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise +9,388 +18% 62,488 14 Mar 2026 Direct F1
transaction ANIK Common Stock Award +4,694 +7.5% $0.000000* 67,182 14 Mar 2026 Direct F2
transaction ANIK Common Stock Tax liability -4,168 -6.2% $14.20* 63,014 14 Mar 2026 Direct F3
transaction ANIK Common Stock Options Exercise +6,449 +10% 69,463 15 Mar 2026 Direct F1
transaction ANIK Common Stock Tax liability -1,893 -2.7% $14.20* 67,570 15 Mar 2026 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise -9,388 -33% $0.000000* 18,777 14 Mar 2026 Common Stock 9,388 Direct F1, F5
transaction ANIK Restricted Stock Unit Options Exercise -6,449 -50% $0.000000* 6,448 15 Mar 2026 Common Stock 6,449 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
F2 On March 14, 2025, the Reporting Person was granted 14,082 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.
F3 Reflects an aggregate of 4,694 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.
F4 Reflects an aggregate of 1,893 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.
F5 On March 14, 2025, the Reporting Person was granted 28,165 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.
F6 On March 15, 2024, the Reporting Person was granted 19,345 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.